Introduction
Hypogonadism is a condition in which the gonads, the testes in males or the ovaries in females, produce too little sex hormone, too few functional gametes, or both. In practical terms, it reflects a failure of the reproductive endocrine system to maintain normal levels of testosterone, estrogen, and related hormones that depend on gonadal function. The condition can arise from problems in the gonads themselves or from disruption of the signals that normally regulate them, especially the hypothalamus and pituitary gland.
The defining biology of hypogonadism involves impaired hormone production, altered feedback control within the hypothalamic-pituitary-gonadal axis, and reduced support for the tissues that depend on sex steroids. Because sex hormones influence reproductive development, fertility, bone turnover, body composition, and multiple other systems, hypogonadism is not only a disorder of reproduction but also a disorder of endocrine regulation more broadly.
The Body Structures or Systems Involved
The central system involved in hypogonadism is the hypothalamic-pituitary-gonadal axis. This is a regulatory loop linking the brain to the reproductive glands. The hypothalamus releases gonadotropin-releasing hormone, or GnRH, in pulses. In response, the pituitary gland secretes luteinizing hormone, or LH, and follicle-stimulating hormone, or FSH. These hormones act on the gonads to stimulate sex hormone production and the development of sperm or eggs.
In males, the testes are the primary gonads affected. Leydig cells in the testes produce testosterone in response to LH, while Sertoli cells respond to FSH and testosterone by supporting sperm production. Testosterone also enters circulation and is converted in some tissues to dihydrotestosterone or estradiol, which contribute to local and systemic effects.
In females, the ovaries are the main affected organs. The ovarian follicles produce estradiol, progesterone, and small amounts of androgens under the control of LH and FSH. These hormones regulate the menstrual cycle, follicle maturation, ovulation, and preparation of reproductive tissues for potential pregnancy.
Other tissues are involved because they respond to sex steroids. Bone, muscle, adipose tissue, the brain, blood vessels, and the reproductive tract all depend to varying degrees on androgen and estrogen signaling. When gonadal hormone output falls, these downstream tissues receive less stimulation and their normal physiology changes.
How the Condition Develops
Hypogonadism develops when the body cannot generate an adequate gonadal hormone response. This can happen at several levels. In primary hypogonadism, the gonads themselves are damaged or underdeveloped, so they cannot produce enough hormones even when LH and FSH signals are present. In secondary hypogonadism, the problem lies higher in the regulatory chain, usually in the hypothalamus or pituitary gland, which then fails to stimulate the gonads appropriately. Some cases reflect combined or functional disturbances affecting more than one point in the axis.
Under normal conditions, GnRH is released in pulses rather than continuously. These pulses maintain pituitary sensitivity and drive LH and FSH secretion. LH and FSH then act on target cells in the testes or ovaries to support steroidogenesis and gamete maturation. Sex hormones feed back to the hypothalamus and pituitary to regulate the next cycle of release. Hypogonadism emerges when this sequence breaks down, whether through tissue loss, hormonal resistance, impaired signaling, or loss of neural control of GnRH pulsatility.
At the cellular level, the gonads may become less responsive to gonadotropins because of developmental defects, injury, inflammation, genetic abnormalities, or age-related decline. In other cases, the brain fails to deliver the proper hormonal signal. Pituitary tumors, infiltrative disorders, head trauma, chronic systemic illness, or medications can suppress gonadotropin release. When the pituitary output drops, the gonads receive insufficient stimulation and steroid synthesis declines.
Hormone production itself is a multistep enzymatic process. Cholesterol is converted through several biochemical pathways into testosterone, estradiol, and progesterone. If any part of this machinery is disrupted, hormone output falls. Thus, hypogonadism may reflect not only gland failure but also impaired steroidogenic enzymes, defective receptor signaling, or reduced availability of the cells that normally carry out these reactions.
Structural or Functional Changes Caused by the Condition
The main functional change in hypogonadism is reduced sex steroid production. In males, low testosterone alters sperm production, libido, erythropoiesis, muscle protein synthesis, and the maintenance of secondary sexual characteristics. In females, low ovarian hormone output affects ovulation, endometrial cycling, and the hormonal environment required for normal reproductive function. The immediate change is endocrine, but the effects spread to multiple tissues that depend on sex hormones for normal regulation.
Structurally, the gonads may show underdevelopment, loss of germ cells, fibrosis, or reduced functional cell mass depending on the cause. In primary testicular failure, seminiferous tubules may lose germinal epithelium, and Leydig cell function may be diminished. In ovarian failure, follicles may be depleted or fail to mature properly. These changes reduce the organ’s capacity to produce both hormones and gametes.
Because sex steroids help preserve bone remodeling balance, their deficiency shifts bone turnover toward resorption. Over time, this can lower bone mineral density. In muscle, reduced anabolic signaling leads to loss of lean tissue and decreased muscle efficiency. Adipose tissue may increase because of altered energy partitioning and reduced hormone-mediated regulation of fat metabolism.
Functional changes also occur in the hypothalamus and pituitary because feedback signals are altered. In primary hypogonadism, low sex hormone levels usually remove negative feedback, so LH and FSH may rise as the pituitary attempts to stimulate the gonads. In secondary hypogonadism, LH and FSH are often low or inappropriately normal because the upstream signaling defect prevents an appropriate response. This hormone pattern helps distinguish the level at which the axis is failing.
Factors That Influence the Development of the Condition
Several biological factors influence whether hypogonadism develops. Genetic abnormalities can affect gonadal development, hormone synthesis, or hormone receptor function. Some inherited conditions interfere with sex chromosome composition, while others alter enzymes required for steroid production or proteins needed for hypothalamic-pituitary signaling. These defects can impair the formation of functional gonadal tissue from early development onward.
Damage to the gonads is another major influence. In the testes, this may result from infection, torsion, trauma, radiation, chemotherapy, autoimmune attack, or congenital absence of germ cells. In the ovaries, follicular depletion, autoimmune destruction, chemotherapy, or premature exhaustion of the ovarian reserve can reduce hormone production. The key mechanism is loss of the cells responsible for steroidogenesis or gamete support.
Disorders of the hypothalamus and pituitary also shape risk. Tumors, infiltrative disease, surgery, radiation, congenital defects, and inflammatory or traumatic injury can reduce GnRH, LH, or FSH output. Chronic systemic illness can suppress the axis through stress-related signaling pathways and altered metabolic cues. When the body interprets illness or energy deficiency as a state incompatible with reproduction, GnRH pulsatility may decline.
Metabolic and endocrine factors can contribute as well. Excess body fat, severe undernutrition, insulin resistance, thyroid disease, and elevated prolactin can all disrupt the normal hormonal signals that support gonadal function. These influences do not all act through one pathway, but they converge on the same outcome: reduced effective stimulation of the gonads or reduced ability of the gonads to respond.
Variations or Forms of the Condition
Hypogonadism is usually classified as primary or secondary, and this distinction reflects the underlying physiology. Primary hypogonadism originates in the gonads. The endocrine signal from the brain may be intact, but the testes or ovaries cannot respond adequately. Secondary hypogonadism originates in the hypothalamus or pituitary, where the hormonal drive to the gonads is insufficient.
There is also a functional form in which the gonadal axis is structurally intact but suppressed by another physiological state. Severe illness, significant caloric deficiency, excessive exercise, chronic stress, and some medications can reduce GnRH secretion or pituitary responsiveness without permanent destruction of the glands. In these cases, the body shifts into a low-reproductive state because reproduction is biologically costly.
Another variation is partial versus complete hypogonadism. Partial forms preserve some hormone production or gamete function, so the endocrine disturbance is incomplete. Complete forms represent near-total failure of gonadal output. The degree of impairment depends on how many hormone-producing cells remain functional and how much signaling still reaches them.
Hypogonadism can also differ by timing. If it begins before puberty, it affects sexual maturation and the development of secondary sexual characteristics because the body never receives the usual hormonal signals needed to initiate pubertal change. If it develops after puberty, the individual may lose previously established hormonal support, and the effects are often more about maintenance than development. These timing differences reflect whether the condition disrupts maturation, maintenance, or both.
How the Condition Affects the Body Over Time
Persistent hypogonadism can create gradual, system-wide changes because sex hormones are involved in long-term tissue maintenance. In the skeleton, prolonged deficiency reduces bone mineral accrual or accelerates bone loss, increasing the risk of fragility over time. In muscle, chronic low anabolic signaling can lead to declining strength and reduced physical capacity. In reproductive tissues, long-term under-stimulation may impair fertility and alter tissue structure.
The body may partially adapt to hormone deficiency, but these adaptations are limited. The pituitary often increases LH and FSH output in primary hypogonadism, attempting to stimulate the failing gonads. This compensation does not restore normal function if the gonads cannot respond. In secondary hypogonadism, the low gonadotropin output may persist quietly if the underlying defect remains, so the gonads continue to receive inadequate stimulation.
Over time, chronic deficiency can also change metabolic regulation. Sex steroids influence lipid handling, insulin sensitivity, and energy distribution. Reduced levels can shift the body toward increased fat accumulation and altered metabolic balance. Because sex steroids also affect brain function, long-term deficiency can influence mood, motivation, and cognitive processes, although the exact pattern depends on the individual and on the cause of the hormone loss.
If hypogonadism begins early in life, the effects on growth and maturation can be more pronounced because the body never receives the hormonal cues required for typical pubertal progression. If it appears later, the body may initially preserve outward function, but internal tissue maintenance progressively declines. The duration and severity of hormone deficiency determine how much structural change accumulates.
Conclusion
Hypogonadism is a disorder of gonadal hormone production caused by dysfunction in the testes or ovaries, or by impaired signaling from the hypothalamus and pituitary gland. Its biology is centered on the hypothalamic-pituitary-gonadal axis, a feedback system that controls sex hormone synthesis and reproductive cell development. When this axis fails, sex steroid levels fall and the tissues that depend on those hormones lose normal support.
Understanding hypogonadism requires attention to both structure and mechanism: the gonads, the brain, the pituitary gland, and the biochemical pathways of steroid production all contribute to the condition. Different causes produce different patterns of hormone change and tissue response, but the underlying issue is the same: the body can no longer maintain normal gonadal endocrine function.